Estelle Ayme-Dietrich

6PUBLICATIONS
16CO-AUTHORS
Predictive and prognostic markersGene and molecular therapyMedical infection agents (incl. prions)Molecular targetsBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 25, 2026
A descriptive case series of hepatotoxicity associated with CFTR modulators and possible relevance of pharmacogenetic polymorphisms in cystic fibrosis patients.

|Nov 25, 2024
French-Speaking Network of Pharmacogenetics (RNPGx) Recommendations for Clinical Use of Mavacamten.

Louis Lebreton, Jean-Christophe Boyer, Claire Lafay-Chebassier

|Jun 05, 2024
Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults.

Estelle Ayme-Dietrich, Florentia Kaguelidou, Gilles Bertschy

|Sep 02, 2021
Characterization of the spontaneous degenerative mitral valve disease in FVB mice.

Estelle Ayme-Dietrich, Sylvia Da Silva, Ghina Alame Bouabout

|Aug 20, 2021
Angiotensin-converting enzyme inhibitor induced angioedema: not always a class effect? A case report and short narrative review.

Guillaume Becker, Fabien Rougerie, Amelia-Naomi Sabo

|Aug 15, 2017
The role of 5-HT2B receptors in mitral valvulopathy: bone marrow mobilization of endothelial progenitors.

Estelle Ayme-Dietrich, Roland Lawson, Francine Côté

Pageof 1

Frequent Collaborators

2 joint publications

Guillaume Becker

2 joint publications

Laurent Monassier

2 joint publications

Laurent Chouchana

1 joint publications

Florentia Kaguelidou